AFP and hepatocellular carcinoma: In addition to the survival benefit of AFP testing in our present work, recent investigations of the accuracy of HCC surveillance techniques have reported greater sensitivity of US and AFP for early stage HCC in cirrhotics compared to US alone,[6] and a lower false-positive rate for AFP than for US.[34] Indeed, the most recently updated oncology and hepatology guidelines (re)introduce AFP.[12,13]